Eisai Asks 3rd Circ. To Rehear Lovenox Antitrust Suit

By Jeff Zalesin · May 19, 2016, 6:13 PM EDT

Pharmaceutical company Eisai asked the full Third Circuit on Wednesday to revisit the company's bid to revive an antitrust suit against Sanofi, arguing that the panel set a harmful precedent for...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Petition

Case Information

Case Title

Eisai Inc v. Sanofi Aventis U.S. LLC, et al

Case Number

Court

Appellate - 3rd Circuit

Nature of Suit

3410 Antitrust

Date Filed

April 28, 2014

Recent Articles By Jeff

June 27, 2016
8 Wasn't Enough For Lawyers Seeking High Court Clarity
June 21, 2016
FTC Hospital Merger Loss Tees Up Fight Over Market Test
June 20, 2016
Suboxone Buyers Slam Comparison To Sanofi's Antitrust Win
June 14, 2016
Hospital Merger Losses Could Prod FTC To Rethink Markets
May 13, 2016
FTC Orders Divestitures For Air Liquide's $13B Airgas Deal
May 10, 2016
FTC's Pa. Merger Loss Puts Obamacare Defense On The Table
May 09, 2016
FTC, Pa. Can't Block Hospital Merger
May 05, 2016
6th Circ. Won't Rehear Ohio Hospital Conspiracy Case
March 30, 2016
FTC, Pa. Ordered To Unveil Whole Hospital Merger Complaint
March 25, 2016
Express Scripts Says Pharmacies Don't Show Conspiracy